Fortress Biotech, Inc. (FBIO) vs RenovoRx, Inc. (RNXT)
Fortress Biotech, Inc. and RenovoRx, Inc. are both Biotechnology companies. Fortress Biotech, Inc. and RenovoRx, Inc. are of similar size ($76.0M and $75.8M). RenovoRx, Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.7×. Fortress Biotech, Inc. has the higher net margin (151.0% vs −621.7%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 16 metrics below, Fortress Biotech, Inc. leads on 12 and RenovoRx, Inc. on 4.
Valuation
Profitability
| Metric | FBIO | RNXT | Biotechnology median |
|---|---|---|---|
| Gross margin | 65.59% | 84.41% | 65.16% |
| Operating margin | (42.61%) | (685.22%) | 0.00% |
| Net margin | 150.98% | (621.71%) | 0.00% |
| Free cash flow margin | 183.80% | (604.10%) | 0.00% |
| Return on equity | 84.91% | (125.23%) | (57.72%) |
| Return on assets | 43.38% | (97.83%) | (49.22%) |
| Return on invested capital | (41.34%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack